In 2023, i+solutions set out to extend its products catalogue and to deliver procurement services also to the private sector. A procurement platform, called XS2Meds, aimed at bridging the gap in access to non-communicable disease medicines in Low- and Middle-Income Countries was developed. XS2Meds is a transparent, neutral, competitive, and efficient market platform for the private sector. External funding for this initiative was secured from impact investor Invest International.

In 2023, the online order intake platform was developed, a website xs2meds.org and LinkedIn account were created. i+solutions closed several agreements with key suppliers like Sanofi, Pfizer, and Novartis, placing orders for buying entities in Rwanda, Zimbabwe and Kyrgyzstan. Orders worth USD 340 thousand, mainly for diabetes medicines, were placed. By connecting private market players with generic regional and international manufacturers, XS2Meds streamlines the supply chain, reducing costs and making quality medicines more accessible to underserved populations.